PFBT
KNSA icon

Parkside Financial Bank & Trust’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-45
Closed -$1.13K – 2162
2024
Q3 		$1.13K Buy
+45
New +$1.1K ﹤0.01% 1685

Other funds holding KNSA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Parkside Financial Bank & Trust's KNSA Position: Q4 2024 in Review

Parkside Financial Bank & Trust sold out of Kiniksa Pharmaceuticals (KNSA) in Q4 2024, closing a stake of 45 shares — an estimated $1.13K sold.

Parkside Financial Bank & Trust first reported a position in KNSA in Q3 2024 and held it in 1 quarter. The position peaked at $1.13K in Q3 2024. 160 funds tracked by Wall St. Rank hold KNSA as of Q4 2024.

  • Parkside Financial Bank & Trust reported no remaining Kiniksa Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 45 Kiniksa Pharmaceuticals shares in Q4 2024, an estimated $1.13K.
  • Parkside Financial Bank & Trust first reported a position in Kiniksa Pharmaceuticals in Q3 2024 and held it in 1 quarter.
  • Parkside Financial Bank & Trust's Kiniksa Pharmaceuticals position peaked at $1.13K in Q3 2024.
  • 160 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q4 2024.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2024, filed 5 Feb 2025.